Scarica l'app Stockscreener
1.35
0.75%
0.01
Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie
MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program - Lohud
MIRA Pharmaceuticals (MIRA) Sets Sights on Major Advancements | - GuruFocus
MIRA Pharmaceuticals (MIRA) Sets Sights on Major Advancements | MIRA Stock News - GuruFocus
MIRA Pharmaceuticals Joins BIO Convention for Strategic Opportunities - TipRanks
MIRA's Novel Pain Drug Shows Promise: Phase 1 Success Leads to Phase 2 Plans as Acquisition Nears - Stock Titan
MIRA Pharmaceuticals announces clinical progress and acquisition update - Investing.com
MIRA Pharmaceuticals announces clinical progress and acquisition update By Investing.com - Investing.com Canada
MIRA Pharmaceuticals board approves SKNY Pharmaceuticals acquisition; combined value tops $60M - MSN
MIRA Pharmaceuticals appoints new CFO - Investing.com Australia
MIRA Pharmaceuticals Appoints New Chief Financial Officer - TipRanks
MIRA Pharmaceuticals appoints new CFO By Investing.com - Investing.com UK
MIRA Pharma Stock Soars To 2-Month High On $60M SKNY Deal: Retail Sentiment Strong - MSN
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
MIRA Pharmaceuticals (MIRA) Projected to Post Earnings on Monday - Defense World
Why Mira Pharmaceuticals Inc (NASDAQ: MIRA) Is A Great Stock Pick For Momentum Investors - Stocksregister
MIRA Pharma Stock Soars To 2-Month High On $60M SKNY Deal: Retail Sentiment Strong By Stocktwits - Investing.com India
MIRA Pharmaceuticals Acquires SKNY Pharmaceuticals for $60M - TipRanks
MIRA Pharmaceuticals to acquire SKNY in strategic move - Investing.com
MIRA Pharmaceuticals Announces Board Approval of SKNY Acquisition Reflecting $60+ Million in Combined Enterprise Value Based on Independent Review - Corsicana Daily Sun
EXCLUSIVE: Mira Pharmaceuticals Board Approves SKNY Pharma Acquisition, Establishing Combined Enterprise Value Over $60 Million - Benzinga
Renaissance Technologies LLC Takes Position in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World
MIRA Pharmaceuticals Reports No Brain Toxicity in FDA-Required Study of Ketamir-2, Confirming Absence of Ketamine-Linked Neurotoxicity - The Joplin Globe
MIRA Achieves Positive Safety Results in Neurotoxicity Study | M - GuruFocus
EXCLUSIVE: MIRA Pharmaceuticals Lead Program Ketamir-2 Shows No Brain Toxicity In FDA-Mandated Study - AOL.com
MIRA Pharmaceuticals reports safe profile for Ketamir-2 - Investing.com
MIRA Pharmaceuticals reports safe profile for Ketamir-2 By Investing.com - Investing.com UK
MIRA Pharmaceuticals Completes Key Neurotoxicity Study for Ketamir-2 - TipRanks
Breakthrough: New Drug Outperforms Ketamine in FDA Brain Safety StudyZero Toxicity Detected - Stock Titan
Pharmaceutical Stock Jumps After Key Trial Findings - MSN
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Down 14.1% in April - Defense World
Mira Pharmaceuticals Inc [MIRA] moved up 7.08: Why It’s Important - dbtnews.com
Financial Metrics Unveiled: Mira Pharmaceuticals Inc (MIRA)’s Key Ratios in the Spotlight - DWinneX
MIRA Pharmaceuticals reports positive in vitro drug release data for topical Ketamir-2 - MSN
Mira Pharmaceuticals announces key drug development milestone By Investing.com - Investing.com Canada
Mira Pharmaceuticals announces key drug development milestone - Investing.com Australia
MIRA Pharmaceuticals (MIRA) Advances Ketamir-2 Formulations in P - GuruFocus
MIRA Pharmaceuticals reports positive Ketamir-2 study By Investing.com - Investing.com India
MIRA Pharmaceuticals reports positive Ketamir-2 study - Investing.com
MIRA Pharmaceuticals Reports Positive In Vitro Drug Release Data for Topical Ketamir-2, Targeting $11B+ U.S. Topical Pain Relief Market and Exploring FDA Fast Track Designation - Weatherford Democrat
Press Release Distribution & PR Platform - ACCESS Newswire
MIRA's Novel Pain Treatment Delivers Positive Data, Targets Massive $11.5B Market With Fast-Track Potential - Stock Titan
Mira Pharmaceuticals Inc (MIRA) is a good investment, but the stock may be undervalued - uspostnews.com
MIRA’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com
Promising Canadian Stocks To Follow Now – April 16th - Defense World
0.17%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):